New insights on the lowest dose for mandatory folic acid fortification?

American Journal of Clinical Nutrition

Volumn 93, Issue 1, 2011, Pages 1-2

  Verhoef, Petra ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG SAFETY; EDITORIAL; RISK ASSESSMENT; VITAMIN BLOOD LEVEL;

FOLIC ACID; FOOD, FORTIFIED; HOMOCYSTEINE; HUMANS; NEURAL TUBE DEFECTS;

EID: 78651284017     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.006387     Document Type: Editorial

References (18)

1. Berry RJ, Bailey L, Mulinare J, Bower C; Folic Acid Working Group. Fortification of flour with folic acid. Food Nutr Bull 2010;31(suppl):S22-35.
2. De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010;10:CD007950.
3. De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007;357:135-42. (Pubitemid 47057731)
4. Quinlivan EP, Gregory JF. Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr 2003;77:221-5.
5. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005;82:442-50.
6. Cuskelly GJ, Mooney KM, Young IS. Folate and vitamin B12: friendly or enemy nutrients for the elderly. Proc Nutr Soc 2007;66:548-58.
7. Scientific Advisory Committee on Nutrition. Folic acid and colorectal cancer risk: review of recommendation for mandatory folic acid fortification. Available from: http://www.sacn.gov.uk/reports-position-statements (cited October 2009).
8. Clarke R, Halsey J, Lewington S, et al; B-Vitamin Treatment Trialists' Collaboration. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37,485 individuals. Arch Intern Med 2010;170:1622-31.
9. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002;288:2015-22.
10. Finkelstein JD. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med 2007;45:1694-9.
11. van Oort FV, Melse-Boonstra A, Brouwer IA, et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. Am J Clin Nutr 2003;77:1318-23. (Pubitemid 44858452)
12. Tighe P, Ward M, McNulty H, et al. A dose-finding trial of the effect of long-term folic acid intakes: implications for food fortification policy. Am J Clin Nutr 2010;93:11-8.
13. Refsum H, Nurk E, Smith AD, et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 2006;136(suppl):1731S-40S. (Pubitemid 43765389)
14. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998;316:894-8.
15. Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005;82:806-12.
16. Rydlewicz A, Simpson JA, Taylor RJ, Bond CM, Golden MH. The effect of folic acid supplementation on plasma homocysteine in an elderly population. QJM 2002;95:27-35. (Pubitemid 34173290)
17. Molloy AM, Brody LC, Mills JL, Scott JM, Kirke PN. The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. Birth Defects Res A Clin Mol Teratol 2009;85:285-94.
18. Miller ER III, Juraschek S, Pastor-Barriuso R, Bazzano LA, Appel LJ, Guallar E. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. Am J Cardiol 2010;106:517-27.